New grid could make cancer scans sharper, safer
NCT ID NCT04565457
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested whether a special 2D antiscatter grid can improve the quality of cone-beam CT (CBCT) images used during radiation therapy for prostate, head and neck, and upper abdomen cancers. 43 participants received one extra CBCT scan with the grid, and researchers compared image clarity, artifacts, and contrast to standard scans. The goal was to see if the grid reduces image errors and improves tissue visibility, which could help doctors target tumors more precisely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
2D antiscatter grid (device)
What this could lead to
If successful, this technology could improve image clarity in CBCT scans, potentially leading to more accurate radiation therapy targeting.
What could go wrong
This is a small pilot study focused on image quality, not patient outcomes. The improvement may not translate to better treatment results or be adopted widely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado Hospital
Aurora, Colorado, 80045, United States
-
University of Florida Health Proton Therapy Institute
Jacksonville, Florida, 32206, United States